Details of the Drug

General Information of Drug (ID: DM6DLXK)

• Drug Name: JNJ-77242113
• Synonyms: JNJ-2113

Indication

Disease Entry	ICD 11	Status	REF
Psoriasis	EA90	Phase 2	[1]

• Cross-matching ID: TTD ID: DY2GF8

References

• [1] ClinicalTrials.gov (NCT05223868) A Phase 2b Multicenter, Randomized, Placebo Controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis. U.S.National Institutes of Health.